Viral infections represent the most significant challenges to health worldwide and cause a range of diseases, killing millions of people each year.
To this end, this session shall present participants with an overview of viral infections while considering mechanisms of action, clinical manifestations, and the most updated news regarding treatment and prevention. Viruses are quite distinct from bacteria.
As obligate intracellular parasites, they require a host cell to multiply. An understanding of their life cycle, which includes steps like attachment, penetration, replication, and release, is crucial for designing good therapeutic strategies.
This lecture will deal with a variety of viral pathogens, such as influenza, HIV, hepatitis viruses, as well as emerging viruses like SARS-CoV-2, detailing their individual features and health implications for the public. Besides causing damage to the health of humans, viral infections also pose a challenge in most healthcare systems around the globe.
The recent COVID-19 pandemic has spotlighted the need for innovative vaccine development strategies and antiviral therapies.
The participants will be informed of advanced research in vaccine platforms including both mRNA and viral vector vaccines and how they might control and eliminate outbreaks.
In the meantime, we will give you the latest advances in new types of treatment: monoclonal antibodies and small-molecule inhibitors, as well as gene editing, CRISPR - and maybe even the hope that some of these tools can help defeat the viruses.
This session is going to foster interdisciplinary collaboration and knowledge sharing in order to approach jointly the ongoing challenges presented by viral diseases in healthcare, research as well as policy-making environments.
Let’s continue our discussion with leading experts in this field in the future of viral infection management and prevention.
Together, we can make ourselves understand much better and improve responses to these virulent pathogens.